Cargando…

Regorafenib Effects on Human Colon Carcinoma Xenografts Monitored by Dynamic Contrast-Enhanced Computed Tomography with Immunohistochemical Validation

OBJECTIVE: To investigate dynamic contrast-enhanced computed tomography for monitoring the effects of regorafenib on experimental colon carcinomas in rats by quantitative assessments of tumor microcirculation parameters with immunohistochemical validation. MATERIALS AND METHODS: Colon carcinoma xeno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cyran, Clemens C., Kazmierczak, Philipp M., Hirner, Heidrun, Moser, Matthias, Ingrisch, Michael, Havla, Lukas, Michels, Alexandra, Eschbach, Ralf, Schwarz, Bettina, Reiser, Maximilian F., Bruns, Christiane J., Nikolaou, Konstantin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786893/ https://www.ncbi.nlm.nih.gov/pubmed/24098755 http://dx.doi.org/10.1371/journal.pone.0076009

Ejemplares similares

Correlation of Perfusion MRI and (18)F-FDG PET Imaging Biomarkers for Monitoring Regorafenib Therapy in Experimental Colon Carcinomas with Immunohistochemical Validation
por: Eschbach, Ralf S., et al.
Publicado: (2015)

Monitoring Cell Death in Regorafenib-Treated Experimental Colon Carcinomas Using Annexin-Based Optical Fluorescence Imaging Validated by Perfusion MRI
por: Kazmierczak, Philipp M., et al.
Publicado: (2015)

Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation
por: Eschbach, Ralf Stefan, et al.
Publicado: (2017)

Monitoring Early Response to Anti-Angiogenic Therapy: Diffusion-Weighted Magnetic Resonance Imaging and Volume Measurements in Colon Carcinoma Xenografts
por: Schneider, Moritz Jörg, et al.
Publicado: (2014)

(68)Ga-TRAP-(RGD)(3) Hybrid Imaging for the In Vivo Monitoring of α(v)ß(3)-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer
por: Kazmierczak, Philipp M., et al.
Publicado: (2016)

Integrin-targeted quantitative optoacoustic imaging with MRI correlation for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma
por: Kazmierczak, Philipp M., et al.
Publicado: (2018)

In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast media
por: Cyran, Clemens C., et al.
Publicado: (2013)

Reducing tumor growth and angiogenesis using a triple therapy measured with Contrast-enhanced ultrasound (CEUS)
por: Paprottka, Philipp Marius, et al.
Publicado: (2015)

(18)F–FDG-PET/CT and diffusion-weighted MRI for monitoring a BRAF and CDK 4/6 inhibitor combination therapy in a murine model of human melanoma
por: Eschbach, Ralf S., et al.
Publicado: (2018)

Ex Vivo Perfusion-Simulation Measurements of Microbubbles as a Scattering Contrast Agent for Grating-Based X-Ray Dark-Field Imaging
por: Velroyen, Astrid, et al.
Publicado: (2015)

Age determination of vessel wall hematoma in spontaneous cervical artery dissection: A multi-sequence 3T Cardiovascular Magnetic resonance study
por: Habs, Maximilian, et al.
Publicado: (2011)

Computed tomography angiography vs 3 T black-blood cardiovascular magnetic resonance for identification of symptomatic carotid plaques
por: Grimm, Jochen M, et al.
Publicado: (2014)

Non-Contrast-Enhanced MR Angiography at 3 Tesla in Patients with Advanced Peripheral Arterial Occlusive Disease
por: Thierfelder, Kolja M., et al.
Publicado: (2014)

Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by In Vivo High-Resolution CMR - a comparative analysis
por: Grimm, Jochen M, et al.
Publicado: (2012)

Comparison of symptomatic and asymptomatic atherosclerotic carotid plaques using parallel imaging and 3 T black-blood in vivo CMR
por: Grimm, Jochen M, et al.
Publicado: (2013)

Visualization, imaging and new preclinical diagnostics in radiation oncology
por: Cyran, Clemens C, et al.
Publicado: (2014)

Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer
por: Huynh, Hung, et al.
Publicado: (2015)

Immunohistochemical Characterisation of Cell-Type Specific Expression of CK1δ in Various Tissues of Young Adult BALB/c Mice
por: Löhler, Jürgen, et al.
Publicado: (2009)

High resolution carotid black-blood 3T MR with parallel imaging and dedicated 4-channel surface coils
por: Saam, Tobias, et al.
Publicado: (2009)

The Big Picture: Evidence Base and Current Trials in Cardiac CT
por: Hetterich, Holger, et al.
Publicado: (2013)

State of affairs of hybrid imaging in Europe: two multi-national surveys from 2017
por: Gatidis, Sergios, et al.
Publicado: (2019)

Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
por: Kunz, Wolfgang G., et al.
Publicado: (2018)

Deep learning in CT colonography: differentiating premalignant from benign colorectal polyps
por: Wesp, Philipp, et al.
Publicado: (2022)

Expansive arterial remodeling of the carotid arteries and its effect on atherosclerotic plaque composition and vulnerability: an in-vivo black-blood 3T CMR study in symptomatic stroke patients
por: Saam, Tobias, et al.
Publicado: (2016)

Erythema multiforme induced by regorafenib
por: Matsunaga, Mototsugu, et al.
Publicado: (2017)

Interaction Between Sex and Organic Anion‐Transporting Polypeptide 1b2 on the Pharmacokinetics of Regorafenib and Its Metabolites Regorafenib‐N‐Oxide and Regorafenib‐Glucuronide in Mice
por: Fu, Qiang, et al.
Publicado: (2019)

Radiation dose and image quality of high-pitch emergency abdominal CT in obese patients using third-generation dual-source CT (DSCT)
por: Forbrig, Robert, et al.
Publicado: (2019)

Incidence and risk of regorafenib-induced hepatotoxicity
por: Zhao, Bin, et al.
Publicado: (2017)

Experience with regorafenib in the treatment of hepatocellular carcinoma
por: Granito, Alessandro, et al.
Publicado: (2021)

Characterization of Glioblastoma Cells Response to Regorafenib
por: Mongiardi, Maria Patrizia, et al.
Publicado: (2022)

Cost-effectiveness of short-protocol emergency brain MRI after negative non-contrast CT for minor stroke detection
por: Puhr-Westerheide, Daniel, et al.
Publicado: (2021)

A whole-body FDG-PET/CT Dataset with manually annotated Tumor Lesions
por: Gatidis, Sergios, et al.
Publicado: (2022)

Automated Ki-67 Quantification of Immunohistochemical Staining Image of Human Nasopharyngeal Carcinoma Xenografts
por: Shi, Peng, et al.
Publicado: (2016)

Development and immunohistochemical characterization of patient-derived xenograft models for muscle invasive bladder cancer
por: Razzaghdoust, Abolfazl, et al.
Publicado: (2021)

A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study
por: Unseld, Matthias, et al.
Publicado: (2020)

Prevention and management of adverse events related to regorafenib
por: De Wit, Mieke, et al.
Publicado: (2013)

Correction: Incidence and risk of regorafenib-induced hepatotoxicity
por: Zhao, Bin, et al.
Publicado: (2019)

Targeting gastrointestinal stromal tumors: the role of regorafenib
por: Schroeder, Brett, et al.
Publicado: (2016)

Regorafenib adjusted dose for Chilean patients with chemoresistant metastatic colorectal cancer: a case series
por: Leal, José Luis, et al.
Publicado: (2018)

Study on efficacy and safety of transcatheter arterial chemoembolization (TACE) combined with regorafenib and PD-1 antibody versus continued TACE combined with regorafenib in patients with hepatocellular carcinoma after failed second-line treatment with regorafenib
por: Wang, Haochen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_chvi1pot4j9o17hettdspuv5ba